XHKG0919
Market cap10mUSD
Dec 23, Last price
0.09HKD
1D
1.08%
1Q
-9.62%
Jan 2017
-74.59%
IPO
-88.81%
Name
Modern Healthcare Technology Holdings Ltd
Chart & Performance
Profile
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, the People's Republic of China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; and spa and massage services comprising resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, foot treatment, and foot massage services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Cellnoc, Mu-lan Spa, Cellnoc, Veribe, Castille, Dr Plus, Eclat du teint, and Natural Care brand names. In addition, it provides franchise and trademark services in relation to beautification and gymnastic services; advertising services; maid agency services; and management services, as well as food and beverage services. As of March 31, 2022, the company had 30 service centers in Hong Kong; 3 service centers in Mainland China; and 7 service centers in Singapore, as well as 8 be Beauty Shop outlets. Modern Healthcare Technology Holdings Limited is headquartered in Kowloon Bay, Hong Kong.
IPO date
Feb 09, 2006
Employees
876
Domiciled in
HK
Incorporated in
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 454,706 11.91% | 406,327 14.27% | 355,591 -17.58% | |||||||
Cost of revenue | 401,454 | 44,966 | 43,780 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 53,252 | 361,361 | 311,811 | |||||||
NOPBT Margin | 11.71% | 88.93% | 87.69% | |||||||
Operating Taxes | (962) | 1,839 | 2,042 | |||||||
Tax Rate | 0.51% | 0.65% | ||||||||
NOPAT | 54,214 | 359,522 | 309,769 | |||||||
Net income | (9,571) -53.55% | (20,607) -70.05% | (68,808) -154.73% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 56,322 | 25,777 | 56,441 | |||||||
Long-term debt | 155,870 | 54,443 | 73,583 | |||||||
Deferred revenue | 1 | (634) | (626) | |||||||
Other long-term liabilities | 5,099 | 634 | 626 | |||||||
Net debt | (20,564) | (142,210) | (47,899) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 78,656 | 139,816 | 51,306 | |||||||
CAPEX | (14,581) | (14,292) | (80,852) | |||||||
Cash from investing activities | 8,165 | (13,173) | (79,960) | |||||||
Cash from financing activities | (70,599) | (77,309) | (78,460) | |||||||
FCF | (12,871) | 474,277 | 339,232 | |||||||
Balance | ||||||||||
Cash | 193,656 | 177,530 | 127,533 | |||||||
Long term investments | 39,100 | 44,900 | 50,390 | |||||||
Excess cash | 210,021 | 202,114 | 160,143 | |||||||
Stockholders' equity | (497,657) | 441,509 | 481,445 | |||||||
Invested Capital | 803,715 | 39,445 | 123,963 | |||||||
ROIC | 12.86% | 440.03% | 227.54% | |||||||
ROCE | 17.39% | 149.20% | 109.51% | |||||||
EV | ||||||||||
Common stock shares outstanding | 904,484 | 904,484 | 904,484 | |||||||
Price | 0.17 26.92% | 0.13 6.56% | ||||||||
Market cap | 149,240 26.92% | 117,583 6.56% | ||||||||
EV | 194,307 | 277,087 | ||||||||
EBITDA | 129,886 | 448,596 | 402,768 | |||||||
EV/EBITDA | 0.43 | 0.69 | ||||||||
Interest | 28,634 | 1,771 | 2,098 | |||||||
Interest/NOPBT | 53.77% | 0.49% | 0.67% |